scientist
Don't laugh: cinnamon and diabetes
Submitted by Anonymous on Tue, 2010-03-02 23:08
Today in the office, someone came out of left field and asked me what I thought about the use of cinnamon for the control of their hypertension. Keeping a somewhat straight face, I said I would look into it, but hadn't heard much about it.
- Read more
- 1688 reads
Cool name of the day: Harley Benz
Submitted by Anonymous on Sat, 2010-02-27 16:20It's funny how the news cycle can turn regular people just doing their jobs into overnight celebrities.
The Chile quake, obviously, is a huge catastrophe, and it will be days before we fully understand the magnitude of the damage. As a resident of a quake-prone part of the world, I commiserate with residents near Santiago.
- Read more
- 3356 reads
UK Health organization: stop funding homeopathy
Submitted by Anonymous on Wed, 2010-02-24 08:34What amazes me is that there is official funding for homeopathic remedies and even hospitals (!) in the British healthcare system, the NHS.
I applaud the NHS for issuing a strongly-worded statement about homeopathy. Perhaps they are still smarting over the Wakefield MMR autism scandal, and looking for low-hanging fruit to go after.
Homeopathy is founded on several non-rational tenets such as the law of similars, and the concept of "miasms."
- Read more
- 1292 reads
Vitamin C intake may reduce chemotherapy effectiveness
Submitted by Anonymous on Sat, 2008-10-04 14:07- Antioxidants
- Cancer
- Cancer Research
- chemist
- Chemistry
- Chemotherapy
- chemotherapy
- Dr. Heaney and associates
- energy
- Gleevec
- Imatinib
- Kettering Cancer Center
- Mark Heaney
- Medicine
- Memorial Sloan
- New York
- Novartis
- Nutrition
- Oncology
- Orthomolecular medicine
- Pathology
- S National Institute of Health
- scientist
- Technology
- Technology
- treatment of cancer
- U.S National Institute of Health
- Vitamin
- Vitamin C
A study undertaken by Dr. Mark Heaney and colleagues at the Memorial Sloan-Kettering Cancer Center in New York published findings yesterday claiming that Vitamin C supplements may reduce the efficacy of cancer drugs including Novartis' Gleevec. Vitamin C treated human cancer cells were tested with chemotherapy drugs in lab dishes. The drugs administered killed between thirty and seventy percent less tumour cells than if the human cancer cells had not been treated with Vitamin C. The results were published in the medical research journal Cancer Research.
- Read more
- 2209 reads